Testing a new imaging dye for prostate cancer surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests an injection called OTL78 (Zopocianine) that may help surgeons see prostate cancer more clearly during robotic prostate removal. It's for men with aggressive or advanced prostate cancer who are already scheduled for this surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 or older
- You have prostate cancer that is grade group 3 to 5, or has spread beyond the prostate, or has reached nearby lymph nodes
- You are scheduled for robot-assisted prostate removal and lymph node removal as part of your standard care
- You have had a PSMA-PET scan for surgical planning within the last 12 months (or are scheduled for one)
- You agree to use birth control during the study and for 6 weeks after the injection, and not donate sperm for 3 months
- You are not allergic to indocyanine green or any part of the study drug, and your kidney and liver function are adequate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a PSMA-PET scan before prostatectomy can guide surgery in a way that helps preserve sexual function. It may be most helpful if you have certain kinds of prostate cancer and want to keep erections after surgery.
This research study tests a new imaging scan (called 68Ga-OncoACP3-PET/CT) to help find prostate cancer and see where it may have spread. The scan uses a radioactive tracer to help doctors visualize cancer cells and decide on the best treatment options.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
This Phase 1 study tests nanoparticles (tiny particles) that are meant to help surgeons better find and remove prostate cancer tissue during surgery. You may be offered standard prostate surgery plus imaging with a study tracer to guide the operation.
This trial tests a special PET/MRI scan that may help doctors see if prostate cancer has spread to nearby lymph nodes before surgery. It could help guide treatment decisions for men with high-risk prostate cancer.
This trial tests a special dye that helps surgeons see prostate cancer cells during surgery. You may be eligible if you are scheduled for prostate removal surgery.
Hear when a new Prostate Cancer Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.